By rbj
Biofarm (stock symbol BIO), one of the most important drug manufacturers in Romania, reports significant increases in the first half of the year compared to the same period of 2021: turnover increasing by 17% and a net profit...
By rbj
Biofarm, one of the most important drug manufacturers in Romania, reports positive developments for the preliminary results of 2021: turnover of 239 million lei and a net profit of 60 million lei, up 11% compared to 2020. In...
Bucharest, July 1, 2025 - RBJ - Numerous private signals, but also statistical information, show that for over a decade the migration phenomenon has...
GDPR | COOKIES: We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.